Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
Open/View files
Date
2017
Author(s)
Duvallet, Claire
Gibbons, Sean M.
Gurry, Thomas
Alm, Eric J.
Publisher
Nature Publishing Group UK
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Duvallet, Claire, Sean M. Gibbons, Thomas Gurry, Rafael A. Irizarry, and Eric J. Alm. 2017. “Meta-analysis of gut microbiome studies identifies disease-specific and shared responses.” Nature Communications 8 (1): 1784. doi:10.1038/s41467-017-01973-8. http://dx.doi.org/10.1038/s41467-017-01973-8.
Abstract
Hundreds of clinical studies have demonstrated associations between the human microbiome and disease, yet fundamental questions remain on how we can generalize this knowledge. Results from individual studies can be inconsistent, and comparing published data is further complicated by a lack of standard processing and analysis methods. Here we introduce the MicrobiomeHD database, which includes 28 published case–control gut microbiome studies spanning ten diseases. We perform a cross-disease meta-analysis of these studies using standardized methods. We find consistent patterns characterizing disease-associated microbiome changes. Some diseases are associated with over 50 genera, while most show only 10–15 genus-level changes. Some diseases are marked by the presence of potentially pathogenic microbes, whereas others are characterized by a depletion of health-associated bacteria. Furthermore, we show that about half of genera associated with individual studies are bacteria that respond to more than one disease. Thus, many associations found in case–control studies are likely not disease-specific but rather part of a non-specific, shared response to health and disease.
Other Available Sources
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
Collection
Mapped collections